Researchers investigated the therapeutic potential of 5-Aza-4’-thio-2’-deoxycytidine (ATC) in a murine transplantation model of myelodysplastic syndrome. ATC treatment led to transformation of transplanted wild-type bone marrow nucleated cells into lymphoid leukemia.
[Cancer Research]